What's New on Pharminfo.com
Drug Infoline - Professional
Edition
Newly Approved Drugs
- FDA Approves NovoLog
Insulin Analogue for Diabetes
- TNKase, Single-Bolus
Treatment for Myocardial Infarction, Approved by FDA
- Gynazole-1 Approved
for One-Dose Treatment of Vaginal Candidiasis
Drugs Nearing FDA
Approval
- Glucovance Helps
People with Type 2 Diabetes, New Studies Show
Drugs in Clinical
Trials
- Effexor Shown to
Improve Diabetic Neuropathic Pain
- Study Shows Droloxifene
Improves Lipid Levels in Postmenopausal Women
- Tipranavir Exhibits
Antiviral Activity Against PI-Resistant HIV Isolates, Studies Show
Drug Infoline - Consumer Edition
Newly Approved Drugs
FDA
- Approves NovoLog
Insulin for Diabetes
- TNKase, Single-Dose
Treatment for Heart Attack, Approved by FDA
- Gynazole-1 Approved
for One-Dose Treatment of Vaginal Candidiasis
Drugs Nearing FDA
Approval
- Glucovance Helps
People with Type 2 Diabetes, New Studies Show
Drugs in Clinical
Trials
- Effexor Shown to
Improve Diabetic Nerve Pain
- Study Shows Droloxifene
Improves Cholesterol in Postmenopausal Women
- Tipranavir Exhibits
Antiviral Activity Against PI-Resistant HIV Isolates, Studies Show
DrugFAQs
- Gynazole-1 (butoconazole
nitrate) FAQs
- NovoLog (insulin
aspart) FAQs
- TNKase (tenecteplase)
FAQs
|